Thalidomide Survivors Contribution Program

From Health Canada

This program is intended to help meet the lifetime needs of Canadian thalidomide survivors.

It is being delivered by Crawford & Company Canada (also known as Crawford), an independent third-party service provider.

Crawford is responsible for:

  • delivering ongoing support payments
  • managing the Extraordinary Medical Assistance Fund (EMAF)
    • this fund will pay for specialized surgery, home and vehicle adjustments to accommodate survivor disabilities
  • assessing and re-assessing the health status of thalidomide survivors
  • determining the eligibility of people who identify themselves as survivors of thalidomide

Program information

Ongoing lifetime support through the program includes:

  • tax-free payments based on level of disability
    • these will increase by 2% a year
    • payments will continue for the survivor’s lifetime without the need to reapply
  • timely and easy access to the EMAF
    • the EMAF will increase by 2% a year

Program eligibility

You are eligible for support under the program if you:

  • are a Canadian thalidomide survivor who was compensated as per the 1991 Extraordinary Assistance Plan (EAP)
    • there is no need to reapply if you are a thalidomide survivor who already received payment through the EAP
  • meet 1 of the 3 eligibility requirements set out in the 1991 EAP, which are:
    1. verifiable information of the receipt of a settlement from the drug company
    2. documentary proof (for example, medical or pharmacy records) of the maternal use of thalidomide (brand names Kevadon or Talimol) in Canada during the first trimester of pregnancy, or
    3. listing on an existing government registry of thalidomide victims

Information for potential thalidomide survivors

Contact Crawford if you think you are a survivor of thalidomide who has yet to be recognized by the federal government. You will be asked to submit satisfactory proof that you meet 1 of the 3 listed eligibility requirements.

The deadline for submissions is May 31, 2016. Your submission meets the deadline if it is date-stamped on or before the closing date.

Contact information

For information on support for Canadian thalidomide survivors, please contact Crawford.

By phone: 1-877-507-7706
TTY 1-877-627-7027

By e-mail: TSCP-PCST@crawco.ca
Website: Thalidomide Survivors Contribution Program

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: